Abcam sees first-half revenues up 13.5%
AIM-listed bioscience firm Abcam is on track to meet profit forecasts for the full-year after first-half revenues rose by 13.5% in the six months to December 2011.
AIM-listed bioscience firm Abcam is on track to meet profit forecasts for the full-year after first-half revenues rose by 13.5% in the six months to December 2011.
The protein research tools supplier said that the business is performing well, "driven by our strategy of providing a broadening range of high quality products and support to the global protein research community."
Meanwhile, cost control and positive foreign exchange movements mean that both gross and operating margins have improved. This does not take into account the acquisition costs of Ascent Scientific, purchased for £10m in September, and the amortisation of acquisition-related intangible assets.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Abcam's online catalogue stood at 81,818 products at the end of the period, an 18.3% increase compared with the end of 2010. Some 477 products from Ascent Scientific were launched on the catalogue last week under the brand name 'Abcam Biochemicals'.
However, analyst Julie Simmonds from brokerage Collins Stewart has said this morning that the "changing product mix and US market conditions will make it increasingly difficult to maintain the current growth rate."
"Though Abcam has again managed to increase its margins this has only allowed it to maintain its profit expectations. This is likely to be seen as disappointing. The current highly rated valuation requires beating not meeting expectations."
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Government launches full review of parental leave and pay – what could it mean for you?
The government wants parental leave to be fairer - will its shake-up fix the widespread problem for families?
-
Nationwide: House prices see biggest monthly fall in over two years
UK house prices dropped by 0.8% in June, according to Nationwide. We reveal the top-performing and worst-performing regions